Clinical Trial Update: Cannabidiol as a Treatment for AUD Comorbid With PTSD [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial investigating cannabidiol for alcohol use disorder comorbid with PTSD has completed Phase 1 and Phase 2; results were posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• Post-traumatic Stress Disorder

Drugs mentioned

• Cannabidiol (cannabidiol)

Snippet

Sponsor: NYU Langone Health | Conditions: Alcohol Use Disorder, Post Traumatic Stress Disorder | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-06-28